News

Study on implant-based mesh-supported breast reconstruction: results pave way for surgeons to make better decisions

Implant-based breast reconstruction is an established surgical method used when a mastectomy has been performed due to breast cancer or as a prophylactic measure. The primary objectives here are the patient’s quality of life, and achieving a good cosmetic outcome post-surgery. The results from the TiLOOP® Bra study (PRO-BRA) by Prof. Dr Marc Thill et al., recently published in the European Journal of Surgical Oncology 1 , highlight the factors...

pfm Forceps EWF 600 - The first wireless electronic forceps for the histologic lab is now available

Cologne, 22 January 2020 - At the end of January, pfm medical ag will be adding 3 new products to its histotechnology product portfolio: The manual microtome pfm Rotary 3000 Compact, the pfm Cooling Plate TES 5010 and the wireless heated pfm Forceps EWF 600. The products will be presented for the first time in Germany at the 22nd Bamberg Morphology Days, 24-26th January 2020. The pfm Forceps EWF 600 are a new addition to the pfm medical ag...

pfm medical expands portfolio in breast cancer diagnostics through agreement with portable MRI pioneer ClearCut Medical

Israeli medical technology start-up ClearCut Medical has granted pfm medical exclusive European distribution rights for the innovative ClearSight™ system. With the ClearSight™ system, the Cologne-based medical technology company is expanding its breast surgery portfolio with a groundbreaking method for accurate margin evaluation in breast cancer. By enabling the performance of magnetic resonance imaging in an intraoperative environment, the...

Financial performance in 2018: pfm medical continues growth trend from previous year

pfm medical closed the 2018 fiscal year with turnover growth of 4.9%. Total turnover last year increased to EUR 109.9 million from the EUR 104.8 million generated in 2017. The operating result (EBIT) increased to EUR 2.9 million, 37.5% higher than the previous year (EUR 2.1 million). With investments, primarily in production and technology at the biggest production facility in the German state of Saarland, pfm medical continues to drive the...

Growth in CVT portfolio: pfm medical becomes exclusive distributer for EmeryGlide from Nano4Imaging

pfm medical is expanding its cardiovascular product portfolio with the EmeryGlide MR conditional guidewire from Nano4Imaging. The two companies announced their future cooperation at the AEPC Congress in Seville. pfm medical has been successful with its products in the field of cardiovascular therapies both nationally and internationally for many years, especially in interventional pediatric cardiology. With the EmeryGlide pfm medical expands this...

Period

Study on implant-based mesh-supported breast reconstruction: results pave way for surgeons to make better decisions

pfm Forceps EWF 600 - The first wireless electronic forceps for the histologic lab is now available

pfm medical expands portfolio in breast cancer diagnostics through agreement with portable MRI pioneer ClearCut Medical

Financial performance in 2018: pfm medical continues growth trend from previous year

Growth in CVT portfolio: pfm medical becomes exclusive distributer for EmeryGlide from Nano4Imaging